## Abstract The detection of prostate cancer using a blood test has by many standards changed the face of the disease. Despite this tremendous success, there are limitations attributed to the use of prostate specific antigen (PSA) as a means to screen and detect prostate cancer. PSA, as its name im
Is sarcosine a biomarker for prostate cancer?
β Scribed by Haleem J. Issaq; Timothy D. Veenstra
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 55 KB
- Volume
- 34
- Category
- Article
- ISSN
- 1615-9306
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Sarcosine was suggested in a letter to Nature in 2009 as a biomarker for prostate cancer. This communication reviews what has been accomplished to date to determine whether sarcosine is or is not a biomarker for prostate cancer that can replace prostateβspecific antigen tests.
π SIMILAR VOLUMES
## Abstract Somatic hypermethylation of CpG island sequences at __GSTP1__, the gene encoding the Οβclass glutathione Sβtransferase, appears to be characteristic of human prostatic carcinogenesis. To consider the potential utility of this epigenetic alteration as a biomarker for prostate cancer, we
## Abstract The identification of biomarkers capable of providing a reliable molecular diagnostic test for prostate cancer (PCa) is highly desirable clinically. We describe here 4 biomarkers, __UDP__β__N__β__Acetyl__βΞ±β__D__β__galactosamine transferase__ (__GalNAc__β__T3__; not previously associate
## Abstract Prostate cancer is one of the most common male malignancies worldwide, and benign prostatic hyperplasia (BPH) is a common cause of lower urinary tract symptoms in elderly men. Garlic (__Allium sativum__) has been known to have antiβinflammatory, antiβcancer and antioxidant effects. Owin